APP and Alzheimer disease: This study established changes in FC and investigated the relationship between FC and cognitive decline in an Aβ mouse model of AD, Cg-Tg(APPswe,PSEN1dE9)85Dbo (APP/PS1) throughout disease progression, including before plaque deposition, at the beginning stage of plaque deposition, and after significant plaque deposition throughout the brain.